Clinical Trials Directory

Trials / Completed

CompletedNCT06603389

The Development of Psychiatric Non-Suicidal Self-Injury Risk Assessment Scale

The Development of Psychiatric Non-Suicidal Self-Injury Risk Assessment Scale (PNSSI-RAS)

Status
Completed
Phase
Study type
Observational
Enrollment
330 (actual)
Sponsor
Shantou University Medical College · Academic / Other
Sex
All
Age
12 Years – 30 Years
Healthy volunteers
Not accepted

Summary

Non-suicidal self-injury (NSSI) is a growing global mental health challenge, distinct from suicidal behavior, with unique risk factors and mechanisms. Existing risk assessment tools do not focus on differentiating NSSI from suicidal self-harm or comprehensively evaluate risk and protective factors specific to NSSI. There is a lack of clinically applicable, validated scales dedicated to assessing NSSI risk, particularly in psychiatric populations. The present study is made to design the Psychiatric Non-Suicidal Self-Injury Risk Assessment Scale, a 39-item scale that evaluates static/dynamic risk factors and protective factors for NSSI in psychiatric patients.

Detailed description

The initial item pool was created through literature review, semi-structured interviews, and group discussions. Two rounds of the Delphi were employed with twenty experts. We analyzed items using critical ratio, correlation coefficient, factor analysis, and Cronbach's α coefficient. Exploratory factor analysis determined item weights, while reliability analyses evaluated internal consistency, test-retest, inter-observer and split-half methods. In the validity analyses, CVI, construct validity and criterion validity were used. ROC curve established the optimal diagnostic threshold and the risk stratification was performed.

Conditions

Interventions

TypeNameDescription
OTHERPsychiatric Non-Suicidal Self-Injury Risk Assessment Scalesacles or questionnaires

Timeline

Start date
2022-11-01
Primary completion
2023-10-31
Completion
2024-05-28
First posted
2024-09-19
Last updated
2024-09-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06603389. Inclusion in this directory is not an endorsement.